FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133343640> ?p ?o ?g. }

• W2133343640 endingPage "236" @default.
• W2133343640 startingPage "228" @default.
• W2133343640 abstract "(See the editorial commentary by Cochi and Linkins, on pages 169–71.) Background. The Global Polio Eradication Initiative aims to eradicate wild poliovirus by the end of 2012. Therefore, more-immunogenic polio vaccines, including monovalent oral poliovirus vaccines (mOPVs), are needed for supplemental immunization activities. This trial assessed the immunogenicity of monovalent types 1 and 3, compared with that of trivalent oral poliovirus vaccine (tOPV), in South Africa. Methods. We conducted a blinded, randomized, 4-arm controlled trial comparing the immunogenicity of a single dose of mOPV1 (from 2 manufacturers) and mOPV3 (from 1 manufacturer), given at birth, with the immunogenicity of tOPV. Results. Eight hundred newborns were enrolled; 762 (95%) were included in the analysis. At 30 days after vaccine administration, seroconversion to poliovirus type 1 was 73.4% and 76.4% in the 2 mOPV1 arms, compared with 39.1% in the tOPV arm (P < .0000001), and seroconversion to poliovirus type 3 was 58.0% in the mOPV3 arm, compared with 21.2% in the tOPV arm (P < .0000001). The vaccines were well tolerated, and no adverse events were attributed to trial interventions. Conclusion. A dose of mOPV1 or mOPV3 at birth was superior to that of tOPV in inducing type-specific seroconversion in this sub-Saharan African population. Our results support continued use of mOPVs in supplemental immunization activities in countries where poliovirus types 1 or 3 circulate. Clinical Trials Registration. ISRCTN18107202." @default.
• W2133343640 created "2016-06-24" @default.
• W2133343640 creator A5012861249 @default.
• W2133343640 creator A5015195207 @default.
• W2133343640 creator A5021776381 @default.
• W2133343640 creator A5023307949 @default.
• W2133343640 creator A5030479970 @default.
• W2133343640 creator A5030583082 @default.
• W2133343640 creator A5035722434 @default.
• W2133343640 creator A5036590679 @default.
• W2133343640 creator A5052254410 @default.
• W2133343640 creator A5057751097 @default.
• W2133343640 creator A5060189446 @default.
• W2133343640 creator A5065571423 @default.
• W2133343640 creator A5083256983 @default.
• W2133343640 date "2011-12-08" @default.
• W2133343640 modified "2023-10-18" @default.
• W2133343640 title "Randomized Trial of Type 1 and Type 3 Oral Monovalent Poliovirus Vaccines in Newborns in Africa" @default.
• W2133343640 cites W1978206045 @default.
• W2133343640 cites W1978514680 @default.
• W2133343640 cites W2000910430 @default.
• W2133343640 cites W2003027106 @default.
• W2133343640 cites W2035054442 @default.
• W2133343640 cites W2037839436 @default.
• W2133343640 cites W2045970981 @default.
• W2133343640 cites W2052165413 @default.
• W2133343640 cites W2054242013 @default.
• W2133343640 cites W2060195907 @default.
• W2133343640 cites W2084941938 @default.
• W2133343640 cites W2107238457 @default.
• W2133343640 cites W2107376649 @default.
• W2133343640 cites W2329627089 @default.
• W2133343640 cites W4206146649 @default.
• W2133343640 cites W4231125505 @default.
• W2133343640 doi "https://doi.org/10.1093/infdis/jir721" @default.
• W2133343640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22158680" @default.
• W2133343640 hasPublicationYear "2011" @default.
• W2133343640 type Work @default.
• W2133343640 sameAs 2133343640 @default.
• W2133343640 citedByCount "17" @default.
• W2133343640 countsByYear W21333436402012 @default.
• W2133343640 countsByYear W21333436402013 @default.
• W2133343640 countsByYear W21333436402014 @default.
• W2133343640 countsByYear W21333436402015 @default.
• W2133343640 countsByYear W21333436402016 @default.
• W2133343640 countsByYear W21333436402020 @default.
• W2133343640 countsByYear W21333436402021 @default.
• W2133343640 countsByYear W21333436402023 @default.
• W2133343640 crossrefType "journal-article" @default.
• W2133343640 hasAuthorship W2133343640A5012861249 @default.
• W2133343640 hasAuthorship W2133343640A5015195207 @default.
• W2133343640 hasAuthorship W2133343640A5021776381 @default.
• W2133343640 hasAuthorship W2133343640A5023307949 @default.
• W2133343640 hasAuthorship W2133343640A5030479970 @default.
• W2133343640 hasAuthorship W2133343640A5030583082 @default.
• W2133343640 hasAuthorship W2133343640A5035722434 @default.
• W2133343640 hasAuthorship W2133343640A5036590679 @default.
• W2133343640 hasAuthorship W2133343640A5052254410 @default.
• W2133343640 hasAuthorship W2133343640A5057751097 @default.
• W2133343640 hasAuthorship W2133343640A5060189446 @default.
• W2133343640 hasAuthorship W2133343640A5065571423 @default.
• W2133343640 hasAuthorship W2133343640A5083256983 @default.
• W2133343640 hasConcept C126322002 @default.
• W2133343640 hasConcept C159047783 @default.
• W2133343640 hasConcept C159654299 @default.
• W2133343640 hasConcept C168563851 @default.
• W2133343640 hasConcept C187212893 @default.
• W2133343640 hasConcept C197934379 @default.
• W2133343640 hasConcept C203014093 @default.
• W2133343640 hasConcept C2522874641 @default.
• W2133343640 hasConcept C2777451964 @default.
• W2133343640 hasConcept C2779631682 @default.
• W2133343640 hasConcept C2780801004 @default.
• W2133343640 hasConcept C2780868878 @default.
• W2133343640 hasConcept C2908647359 @default.
• W2133343640 hasConcept C4870876 @default.
• W2133343640 hasConcept C535046627 @default.
• W2133343640 hasConcept C71924100 @default.
• W2133343640 hasConcept C99454951 @default.
• W2133343640 hasConceptScore W2133343640C126322002 @default.
• W2133343640 hasConceptScore W2133343640C159047783 @default.
• W2133343640 hasConceptScore W2133343640C159654299 @default.
• W2133343640 hasConceptScore W2133343640C168563851 @default.
• W2133343640 hasConceptScore W2133343640C187212893 @default.
• W2133343640 hasConceptScore W2133343640C197934379 @default.
• W2133343640 hasConceptScore W2133343640C203014093 @default.
• W2133343640 hasConceptScore W2133343640C2522874641 @default.
• W2133343640 hasConceptScore W2133343640C2777451964 @default.
• W2133343640 hasConceptScore W2133343640C2779631682 @default.
• W2133343640 hasConceptScore W2133343640C2780801004 @default.
• W2133343640 hasConceptScore W2133343640C2780868878 @default.
• W2133343640 hasConceptScore W2133343640C2908647359 @default.
• W2133343640 hasConceptScore W2133343640C4870876 @default.
• W2133343640 hasConceptScore W2133343640C535046627 @default.
• W2133343640 hasConceptScore W2133343640C71924100 @default.
• W2133343640 hasConceptScore W2133343640C99454951 @default.
• W2133343640 hasIssue "2" @default.
• W2133343640 hasLocation W21333436401 @default.

• next